US Bancorp’s Pulmonx LUNG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-5,100
Closed -$13.2K 4172
2025
Q2
$13.2K Buy
5,100
+4,944
+3,169% +$19.5K ﹤0.01% 3329
2025
Q1
$1.05K Sell
156
-1,226
-89% -$8.68K ﹤0.01% 3981
2024
Q4
$9.38K Buy
+1,382
New +$9.1K ﹤0.01% 3438
2024
Q2
Sell
-33
Closed -$306 4051
2024
Q1
$306 Hold
33
﹤0.01% 3888
2023
Q4
$421 Sell
33
-143
-81% -$1.49K ﹤0.01% 3862
2023
Q3
$1.82K Sell
176
-1,410
-89% -$16.3K ﹤0.01% 3675
2023
Q2
$20.8K Sell
1,586
-730
-32% -$8.93K ﹤0.01% 2956
2023
Q1
$25.9K Buy
2,316
+1,614
+230% +$15.9K ﹤0.01% 2854
2022
Q4
$5.92K Buy
702
+302
+76% +$2.87K ﹤0.01% 3461
2022
Q3
$7K Sell
400
-66
-14% -$1.22K ﹤0.01% 3489
2022
Q2
$7K Buy
466
+89
+24% +$1.83K ﹤0.01% 3476
2022
Q1
$10K Sell
377
-1,213
-76% -$31.3K ﹤0.01% 3372
2021
Q4
$51K Buy
1,590
+560
+54% +$20.5K ﹤0.01% 2641
2021
Q3
$37K Buy
1,030
+534
+108% +$21K ﹤0.01% 2803
2021
Q2
$22K Buy
+496
New +$21.6K ﹤0.01% 3088

Other funds holding LUNG

US Bancorp's LUNG Position: Q3 2025 in Review

US Bancorp sold out of Pulmonx (LUNG) in Q3 2025, closing a stake of 5,100 shares — an estimated $13.2K sold.

US Bancorp first reported a position in LUNG in Q2 2021 and held it in 15 quarters. The position peaked at $51K in Q4 2021. 107 funds tracked by Wall St. Rank hold LUNG as of Q3 2025.

  • US Bancorp reported no remaining Pulmonx position as of Q3 2025 after selling out during the quarter.
  • US Bancorp sold 5,100 Pulmonx shares in Q3 2025, an estimated $13.2K.
  • US Bancorp first reported a position in Pulmonx in Q2 2021 and held it in 15 quarters.
  • US Bancorp's Pulmonx position peaked at $51K in Q4 2021.
  • 107 funds tracked by Wall St. Rank held Pulmonx as of Q3 2025.

Based on US Bancorp's 13F filing for Q3 2025, filed 12 Nov 2025.